| Detected | Trial | Change |
|---|---|---|
| 2026-07-28 | NCT07141706 A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors |
Trial arms changed: 8 -> 9 |
| 2026-07-28 | NCT07141706 A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors |
Trial sites expanded: 6 -> 14 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06265428 | A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer | HER2-positive Breast Cancer | Active, Not Recruiting |
| NCT06018337 | A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone… | Metastatic Breast Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT06953089 | DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors | Solid Tumors | Recruiting |
| Phase 1/2 | |||
| NCT05914116 | A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors | Advanced Solid Tumors | Recruiting |
| NCT05150691 | A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors | HER2-positive Advanced Solid Tumor | Recruiting |
| NCT05785741 | A Study of DB-1310 in Advanced/Metastatic Solid Tumors | Advanced Solid Tumor | Recruiting |
| NCT07263594 | A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors | Gastrointestinal Cancer | Recruiting |
| NCT06625671 | A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants | Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus | Recruiting |
| NCT06554795 | First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors | Solid Tumor, Adult | Recruiting |
| NCT05438329 | First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors | Advanced Solid Tumor | Active, Not Recruiting |
| Phase 1 | |||
| NCT07141706 | A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors | Advanced/Metastatic Solid Tumors | Recruiting |